LLYX
Defiance Daily Target 2x Long LLY ETFLLYX
LLYX
0
Funds holding %
of 7,372 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
587,071% more capital invested
Capital invested by funds: $354 [Q3] → $2.08M (+$2.08M) [Q4]
984% more call options, than puts
Call options by funds: $477K | Put options by funds: $44K
400% more funds holding
Funds holding: 1 [Q3] → 5 (+4) [Q4]
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
5.82% more ownership
Funds ownership: 0.01% [Q3] → 5.83% (+5.82%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for LLYX.
Financial journalist opinion
Neutral
ETF Trends
3 months ago
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.

Positive
ETF Trends
7 months ago
Defiance Lists Leveraged Eli Lilly ETF
On Thursday, Defiance ETFs rolled out its next leveraged fund, the Defiance Daily Target 2X Long LLY ETF (LLYX). The actively managed LLYX has a net expense ratio of 1.29%.

Charts implemented using Lightweight Charts™